New appointments at PharmAthene
This article was originally published in Scrip
Executive Summary
PharmAthene, a US biodefense company developing medical countermeasures against biological and chemical threats, has promoted Eric Richman from senior vice-president of business development and strategic planning to president and chief operating officer. The company has also promoted Francesca Cook to senior vice-president of policy and government affairs, and Dr Valerie Riddle has been named senior vice-president and medical director, adding oversight of the company's programme management function to her responsibilities.